Drug Profile
Piragliatin
Alternative Names: GK Activator (2); GK2; R1440; RO4389620Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Roche
- Class Antihyperglycaemics; Benzeneacetamides; Pyrazines; Small molecules
- Mechanism of Action Glucokinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 11 Sep 2008 Efficacy data from a phase II trial in Type 2 diabetes presented at the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD-2008)
- 11 Sep 2008 Pharmacokinetics, pharmacodynamics and adverse events data from a phase I trial in Type 2 diabetes mellitus presented at the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD-2008)
- 23 Jul 2007 Discontinued - Phase-II for Type-2 diabetes mellitus in USA (PO)